VANCOUVER, July 15, 2015 - Eyecarrot Innovations Corp ($EYC:CA) is pleased to announce, effective immediately, the appointment of Dr. Brent Norton M.D.,M.B.A.,ICD.D as President, CEO, and Director of the company. Adam Cegielski will move to Chief Product Officer, and Director of the company.
Dr. Norton is an accomplished leader in the Life Science industry with significant experience as a Founder, President, CEO and Director of several successful Life Science companies. Having completed his medical training at McGill University, Dr. Norton subsequently obtained a Masters of Business Administration at the University of Western Ontario's Richard Ivey School of Business and is a certified director from the Institute of Corporate Directors. Dr.Norton was recently President and CEO of MedCurrent Corporation, a private Health IT company, was a founding Director of Novadaq Technologies Inc. ($NDQ:CA) ($NVDQ), as well as holding several other Executive roles and Directorships. He is presently an Advisory Board member for the Ivey Centre for Health Innovation; is a Director of Alpine Ontario, Past President and Director of the Osler Bluff Ski Club and an Advisory Board member for Eve-Medical.
"Dr. Norton has been directly involved in the successful development of multiple Life Science companies from startup through IPO's in Canada and the US. He has built commercial licensing relationships with two of the top five medical companies in the world, directly managed IP development, IT development and product sales, company and IP acquisitions through to out-licensing and outright sales", said Adam Cegielski, Founder of Eyecarrot. "His experience in healthcare roll-up strategies will be invaluable to our company, and his leadership will be paramount as we continue to build out our team".
Kalpesh Rathod will be stepping off the Board of Directors. We would like to thank Mr. Rathod for his contribution to the development of Eyecarrot.
Eyecarrot's mission is to enable Vision Care practitioners globally to drive enhancements of human performance. We are building the BinoviTM Cloud, a universal system for testing and measuring a human's Oculomotor Sensory System performance.
On behalf of the Board of Directors
Founder | CPO
Telephone: 1.855.416.7158 | 416.943.6271
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp.
For further information: Adam Cegielski, Founder, CPO, Telephone: 1.855.416.7158, 416.943.6271
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer